Figure S5 from RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types
Authors
Nathan P. Coussens (ORCID: https://orcid.org/0000-0002-3896-7909)
Beverly A. Teicher (ORCID: https://orcid.org/0000-0003-1535-7304)
James H. Doroshow (ORCID: https://orcid.org/0000-0002-4463-1790)
Thomas E. Silvers (ORCID: https://orcid.org/0009-0003-7907-1177)
Thomas Steven Dexheimer (ORCID: https://orcid.org/0000-0002-6444-3121)
Samantha B. Kemp (ORCID: https://orcid.org/0000-0002-1505-4015)
Figure S5 from RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types
Nathan P. Coussens, Beverly A. Teicher, James H. Doroshow, Thomas E. Silvers et al.
Topics
Colorectal Cancer Treatments and Studies
article
Figure S5 from RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types
Nathan P. Coussens, Beverly A. Teicher, James H. Doroshow, Thomas E. Silvers, Thomas Steven Dexheimer, Samantha B. Kemp, Zahra Davoudi, Melinda G. Hollingshead, Naoko Takebe, Joel Morris, Poorva Juneja, Raymond G. Fox